Polling Station
Poll 02/01/2019 – 31/01/2019
The common femoral artery (CFA) disease
Gender: Male
Age: 73 years old
Comorbidity: Arterial hypertension, hypercholesterinemia, coronary artery disease, previous CABG
Symptoms: Claudication, Rutherford stage 3
Previous operations: None
ABI: 0.5
Question #1
Which is your primary treatment for de novo common femoral artery disease?
- Surgery
- Endovascular treatment
Question #2
Which is the combined morbidity/mortality rate following surgical treatment of common femoral artery disease:
- <5%
- 5-15%
- 16-30%
- 31-50%
- >50%
Question #3
Which of the following characteristics might be an indication for endovascular CFA treatment?
- Severe obesity
- Chronic steroid use
- Prior groin surgery
- Increased comorbidity
- None of them, endovascular treatment is not an option
Question #4
Which of the following modalities would be your primary endovascular CFA treatment option:
- Plain angioplasty
- Drug-coated balloon angioplasty (DCB)
- Vessel preparation and DCB angioplasty
- Bare metal stent
- Drug-eluting stent
- Stent-graft
Question #5
Which of the following characteristics might be a contraindication for the endovascular CFA treatment?
- Concomitant deep femoral artery disease
- Concomitant SFA disease
- Severe calcification
- Young age
- There is no contraindication for endovascular treatment
Question #6
In case of rest pain (Rutherford 4) and coexisitng CFA and SFA disease, do you think that CFA revascularization only is sufficient?
- Yes
- No, I would go also for SFA revascularization/bypass
Question #7
In case of minor tissue loss (Rutherford 5) and coexisitng CFA and SFA disease, do you think that CFA revascularization only is sufficient?
- Yes
- No, I would go also for SFA revascularization/bypass